Takeda is a global pharmaceutical leader that focuses on serving the needs of patients and physicians. The company is involved in various therapeutic areas including gastroenterology, oncology, rare diseases, and immunology. This is self-described.

Takeda

Update em Medicina 2017

EFOMV 2018

YES Meeting 2018

APIC - Reunião Anual 2016

Congresso Português de Hepatologia

TEDx University of Porto

GS1 in EU - REGIONAL FORUM 2016

Tummy Trends

Congresso Hepatologia 2018

Update em Medicina 2018

Viewport Meta

IPhone / Mobile Compatible

Domain Not Resolving

SSL by Default

Google Tag Manager

Apple Mobile Web Clips Icon

HSTS

DNSSEC

Google Maps

Content Delivery Network

Co-Owner

Adrian Łukaszewicz

VP, Head Region US - Oncology and External Supply Small Molecule

Alex Parker

Head of HR and Communications, Member of the Board Austria

Alexandra Hilgers

Computerized System Owner / Global Quality Systems

Andreas Hengstberger

Owner, Instructor

Anne Decker-Beck

Associate Director Global Artwork Processes Owner

Annette Dohmen

Vice President, ABDİBİO & Executive Board Member at Abdi Ibrahim Pharmaceuticals

Aydin Ozuer

Founder/ Owner

Cole Hagen

Director & CFO

Costa Saroukos

Senior Service Owner

Ermis Makis

Jean-Luc Butel

Tadataka Yamada

Emiko Higashi

Sidney Taurel

Jason Marchant

Rekha Paleyanda

Director

Schuyler Fairfield

SVP, Global Head of Supply Chain

Henry Werner

Communication Director Nordics & Baltics

Christopher Barr

Takeda Community Engagement

Bin Li

Director of Computational Biology, Takeda Data Science Institute

Yasuchika Hasegawa

Chairman of the Board & CEO

Masaru Otsuka

Head of Digital Acceleration

Patrycja Lakomiak

Head Of Supply Chain Coordination

Avidity Biosciences is a biotechnology company that develops oligonucleotide-based therapies for its patients.

Alnylam Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization.

Turnstone Biologics is a privately-held clinical stage biotech company.

Ultragenyx Pharmaceutical focuses on the development of various products for the treatment of rare and ultra-rare diseases.

Ascentage is a clinical-stage biopharmaceutical company that develops drugs for the treatment of cancer.

Seagen is a clinical-stage biotechnology company dedicated to improving patient outcomes with advanced antibody-drug conjugate technology.

PvP Biologics is developing an oral enzyme for the treatment of celiac disease.

Xenon Pharmaceuticals operates as a neurology-focused biopharmaceutical company.

Mersana Therapeutics develops a biodegradable polymer platform Fleximer® which creates new and better medicines.

Molecular Templates is a clinical-stage biopharmaceutical company developing therapeutic compounds for cancer and other serious diseases.

Asia Companies (Top 10K)

Health Care Companies With More Than 500 Employees (Top 10K)

Investors Active in Midwestern US

Companies With More Than $1M in Revenue (Top 10K)

Takeda researches, develops, manufactures, sells, markets, imports, and exports pharmaceutical drugs. They offer pharmaceuticals, therapeutics, oncology, and gastroenterology vaccines.

Grant - Takeda

Tokyo

Japan

Asia

Takeda in deal with Alloy Therapeutics to develop cell therapy platforms for cancer (TAK)

Telangana secures over Rs 36,000 crore in life sciences investments, genome valley leads the way

California dengue cases prompt swift response from public health officials

Takeda cuts more jobs in U.S. and Japan amid slow growth

Takeda details another round of layoffs in Massachusetts as restructuring drive rolls on

Takeda terminates deal with Wave

NICE turns down Takeda colorectal cancer drug

Tempus teams withTakeda to leverage multimodal real-world datasets in oncology

Hutchmed, Takeda receive Japan MHLW approval to manufacture and market Fruzaqla

Takeda develops treatments for gastrointestinal diseases and inflammatory conditions.

Takeda focuses on creating therapies for rare diseases, addressing unmet medical needs.

Takeda offers therapies derived from plasma to treat various conditions.

Takeda researches and develops cancer treatments.

Takeda provides treatments for neurological disorders.

Takeda develops vaccines to prevent infectious diseases.

United States

North America

India

Austria

Europe

United Kingdom

HTML5

Bootstrap

Apache Server

Cloudflare CDN

Google Drive

Facebook Comments

Comodo PositiveSSL Certificates

Adobe Fonts

Google Fonts

Takeda owns Takeda Ventures

Takeda owns Takeda Consumer Healthcare

Takeda owns Takeda Cambridge

Takeda owns Takeda California

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Sep 27, 2024 5:44 PM	94c001b5
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Sep 27, 2024 5:44 PM	212d54b1
crunchbase trigger	general	Nov 22, 2024 7:44 AM	0b17c233
crunchbase profile	general	Nov 22, 2024 10:16 AM	3b923935
li profile	general
translate crunchbase fundingrounds	general	Nov 22, 2024 2:22 PM	7d31bc3b
peers	general	Sep 27, 2024 5:44 PM	a2cb229c
news basic	general	Sep 27, 2024 5:44 PM	a2799c93
bundesanzeiger	filings
financials download nd	financials
private financials	financials

BE:TAKEDA

Takeda